Article
Targeting human γδ T cells as a potent and safe alternative to pan-T cells bispecific cell…
medRxiv · 2023 · Boutin, L.; Barjon, C.; Lafrance, L.; Senechal, E.; Bourges, D.; Vigne, E.; Scotet, E.
Key facts
| Title | Targeting human γδ T cells as a potent and safe alternative to pan-T cells bispecific cell engagers |
|---|---|
| First author | Boutin, L.; Barjon, C.; Lafrance, L.; Senechal, E.; Bourges, D.; Vigne, E.; Scotet, E. |
| Journal | medRxiv |
| Published | Jul 11, 2023 |
| DOI | 10.1101/2023.07.10.548307 |
| Devices mentioned | BK110039, DEN000008, K022086 |
| Product codes mentioned | JCI, KIT, MVU, NDS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1